Paradigm BiopharmaceuticalsPAR 
$0.16-4.08%24h
-4.08%24h
Global rank24580
Market cap$46.05M
Change 7d-16.07%
YTD Performance-46.59%
SP500 benchmarkUnderperform
P/E-0.89
P/S1455.83
Revenue$31.63K
Earnings-$35.12M
Dividend yield-
Main Sector
Healthcare
Paradigm Biopharmaceuticals PAR Total Debt
PAR Total Debt in 2022: $160.13K
According to Paradigm Biopharmaceuticals latest financial reports the total debt is $160.13K, an decrease of -49.52% to 2022. At the end of 2022 company had $317.23K total debt. This figure represents the debts and financial obligations that Paradigm Biopharmaceuticals combine short-term debt, long-term debt, and other fixed payment obligations (such as capital leases) of a business that are incurred while under normal operating cycles.
Paradigm Biopharmaceuticals PAR Total Debt History from 2023 to 2022
-
Value:-
PAR Total Debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023 | $160.13K | -49.52% |
| 2022 | $317.23K | -24.03% |
| 2021 | $417.57K | -17.59% |
| 2020 | $506.70K | - |
View the Top Total Debt Stocks 
